Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7365
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas ; day:15 ; month:8 ; year:2016 ; pages:1-7
Metabolic brain disease ; (15.8.2016), 1-7
- Urheber
-
Schwetz, Verena
- Beteiligte Personen und Organisationen
-
Librizzi, Rosaria
Trummer, Christian
Theiler, Georg
Stiegler, Claudia
Pieber, Thomas R.
Obermayer-Pietsch, Barbara
Pilz, Stefan
SpringerLink (Online service)
- DOI
-
10.1007/s11011-016-9882-2
- URN
-
urn:nbn:de:1111-201609121788
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schwetz, Verena
- Librizzi, Rosaria
- Trummer, Christian
- Theiler, Georg
- Stiegler, Claudia
- Pieber, Thomas R.
- Obermayer-Pietsch, Barbara
- Pilz, Stefan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Quo vadis, LDL cholesterol?
Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians
Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials
Overcoming therapeutic inertia in LDL cholesterol-lowering treatment with education and simplified treatment algorithms
Studien zur Bindungscharakteristik von Cholesterol bzw. LDL an verschiedene Chargen LDL-adsorbierender Perlzellulose
Age-and sex-specific reference intervals of total cholesterol, LDL cholesterol, HDL cholesterol and non-HDL cholesterol. Comparison of two algorithms for the indirect estimation of reference intervals
Precipitation of LDL with Sulphopolyanions: A Comparison of Two Methods for LDL Cholesterol Determination
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
LDL cholesterol estimation in patients with the metabolic syndrome
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Quo vadis, LDL cholesterol?
Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians
Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials
Overcoming therapeutic inertia in LDL cholesterol-lowering treatment with education and simplified treatment algorithms
Studien zur Bindungscharakteristik von Cholesterol bzw. LDL an verschiedene Chargen LDL-adsorbierender Perlzellulose
Age-and sex-specific reference intervals of total cholesterol, LDL cholesterol, HDL cholesterol and non-HDL cholesterol. Comparison of two algorithms for the indirect estimation of reference intervals
Precipitation of LDL with Sulphopolyanions: A Comparison of Two Methods for LDL Cholesterol Determination
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
LDL cholesterol estimation in patients with the metabolic syndrome
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Quo vadis, LDL cholesterol?
Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians
Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials
Overcoming therapeutic inertia in LDL cholesterol-lowering treatment with education and simplified treatment algorithms
Studien zur Bindungscharakteristik von Cholesterol bzw. LDL an verschiedene Chargen LDL-adsorbierender Perlzellulose
Age-and sex-specific reference intervals of total cholesterol, LDL cholesterol, HDL cholesterol and non-HDL cholesterol. Comparison of two algorithms for the indirect estimation of reference intervals
Precipitation of LDL with Sulphopolyanions: A Comparison of Two Methods for LDL Cholesterol Determination
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk